Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)
Public ClinicalTrials.gov record NCT00970268. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long-term, Randomized, Double-blind Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide at Two Dose Levels When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this extension study is to evaluate the long-term safety, tolerability, and efficacy of inhaled aclidinium bromide at two dose levels in patients with moderate to severe chronic obstructive pulmonary disease (COPD). This study will be 54 weeks in duration; a 52-week double-blind treatment period and 2 week follow-up phone call, following a 12 week lead-in study. All patients will be randomized from the lead-in study at one of two doses of aclidinium.
Study identification
- NCT ID
- NCT00970268
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 291 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2009 (Type not available)
- Primary completion
- Oct 2010 (Actual)
- Completion
- Oct 2010 (Actual)
- Last update posted
- Jan 6, 2017
2009 – 2010
United States locations
- U.S. sites
- 77
- U.S. states
- 27
- U.S. cities
- 71
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 1162 | Birmingham | Alabama | 35209 | — |
| Forest Investigative Site 1127 | Mobile | Alabama | 36608 | — |
| Forest Investigative Site 0909 | Glendale | Arizona | 85306 | — |
| Forest Investigative Site 2060 | Phoenix | Arizona | 85023 | — |
| Forest Investigative Site 2065 | Fullerton | California | 92835 | — |
| Forest Investigative Site 1088 | Lakewood | California | 90712 | — |
| Forest Investigative Site 1122 | Orange | California | 92868 | — |
| Forest Investigative Site 2029 | Rancho Mirage | California | 92270 | — |
| Forets Investigative Site 2064 | Riverside | California | 92506 | — |
| Forest Investigative Site 0517 | Sacramento | California | 95821 | — |
| Forest Investigative Site 2009 | San Diego | California | 92120 | — |
| Forest Investigative Site 1137 | Colorado Springs | Colorado | 80907 | — |
| Forest Investigative Site 2100 | Waterbury | Connecticut | 06708 | — |
| Forest Investigative Site 1154 | Brandon | Florida | 33511 | — |
| Forest Investigative Site 1152 | Clearwater | Florida | 33765 | — |
| Forest Investigative Site 0670 | DeLand | Florida | 32720 | — |
| Forest Investigative Site 0990 | Fort Lauderdale | Florida | 33316 | — |
| Forest Investigative Site 1167 | Melbourne | Florida | 32935 | — |
| Forest Investigative Site 1060 | Ormond Beach | Florida | 32174 | — |
| Forest Investigative Site 0974 | Pensacola | Florida | 32504 | — |
| Forest Investigative Site 2082 | Tamarac | Florida | 33321 | — |
| Forest Investigative Site 2053 | Tampa | Florida | 33606 | — |
| Forest Investigative Site 2047 | Tampa | Florida | 33613 | — |
| Forest Investigative Site 1185 | Winter Park | Florida | 32789 | — |
| Forest Investigative Site 1183 | Atlanta | Georgia | 30329 | — |
| Forest Investigative Site 0987 | Austell | Georgia | 30106 | — |
| Forest Investigative Site 1101 | Blue Ridge | Georgia | 30513 | — |
| Forest Investigative Site 1180 | Decatur | Georgia | 30033 | — |
| Forest Investigative Site 1161 | Duluth | Georgia | 30096 | — |
| Forest Investigative Site 2051 | River Forest | Illinois | 60305 | — |
| Forest Investigative Site 0989 | Skokie | Illinois | 60076 | — |
| Forest Investigative Site 1149 | South Bend | Indiana | 46617 | — |
| Forest Investigative Site 2085 | Crescent Springs | Kentucky | 41017 | — |
| Forest Investigative Site 0539 | Lexington | Kentucky | 40504 | — |
| Forest Investigative Site 2024 | Lafayette | Louisiana | 70503 | — |
| Forest Investigative Site 2040 | Biddeford | Maine | 04005 | — |
| Forest Investigative Site 1128 | Edina | Minnesota | 55435 | — |
| Forest Investigative Site 2041 | Minneapolis | Minnesota | 55402 | — |
| Forest Investigative Site 1124 | Minneapolis | Minnesota | 55407 | — |
| Forest Investigative Site 1100 | Florissant | Missouri | 63033 | — |
| Forest Investigative Site 2079 | Saint Charles | Missouri | 63301 | — |
| Forest Investigative Site 2067 | Butte | Montana | 59701 | — |
| Forest Investigative Site 1169 | Papillion | Nebraska | 68406 | — |
| Forest Investigative Site 1150 | Berlin | New Jersey | 08009 | — |
| Forest Investigative Site 2084 | Summit | New Jersey | 07901 | — |
| Forest Investigative Site 1147 | Brooklyn | New York | 11234 | — |
| Forest Investigative Site 1119 | Elmira | New York | 14901 | — |
| Forest Investigative Site 1151 | New Hyde Park | New York | 11040 | — |
| Forest Investigative Site 1141 | New York | New York | 10016 | — |
| Forest Investigative Site 1163 | New York | New York | 10016 | — |
| Forest Investigative Site 1130 | Asheville | North Carolina | 28801 | — |
| Forest Investigative Site 1134 | Canton | Ohio | 44718 | — |
| Forest Investigative Site 1181 | Centerville | Ohio | 45459 | — |
| Forest Investigative Site 1136 | Cincinnati | Ohio | 45227 | — |
| Forest Investigative Site 2007 | Cincinnati | Ohio | 45231 | — |
| Forest Investigative Site 2028 | Cincinnati | Ohio | 45242 | — |
| Forest Investigative Site 0959 | Columbus | Ohio | 43215 | — |
| Forest Investigative Site 2006 | Columbus | Ohio | 43215 | — |
| Forest Investigative Site 2043 | Medford | Oregon | 97504 | — |
| Forest Investigative Site 1106 | Portland | Oregon | 97213 | — |
| Forest Investigative Site 1126 | Bethlehem | Pennsylvania | 18020 | — |
| Forest Investigative Site 2016 | Erie | Pennsylvania | 16506 | — |
| Forest Investigative Site 1146 | Pittsburgh | Pennsylvania | 15243 | — |
| Forest Investigative Site 1158 | Upland | Pennsylvania | 19013 | — |
| Forest Investigative Site 1089 | East Providence | Rhode Island | 02914 | — |
| Forest Investigative Site 1144 | Johnston | Rhode Island | 02919 | — |
| Forest Investigative Site 2072 | Charleston | South Carolina | 29406 | — |
| Forest Investigative Site 1078 | Greenville | South Carolina | 29615 | — |
| Forest Investigative Site 2080 | Greer | South Carolina | 29651 | — |
| Forest Investigative Site 1121 | Spartanburg | South Carolina | 29303 | — |
| Forest Investigative Site 1155 | Dallas | Texas | 75231 | — |
| Forest Investigative Site 2012 | Fort Worth | Texas | 76104 | — |
| Forest Investigative Site 1165 | San Antonio | Texas | 78229 | — |
| Forest Investigative Site 1129 | Waco | Texas | 76712 | — |
| Forest Investigative Site 2099 | Richmond | Virginia | 23225 | — |
| Forest Investigative Site 1142 | Spokane | Washington | 99204 | — |
| Forest Investigative Site 0988 | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00970268, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 6, 2017 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00970268 live on ClinicalTrials.gov.